Mortality News and Research

RSS

Insight into the future of genetic testing

In this interview, we speak to Sheetal Parmar, vice president of medical affairs and head of clinical services at Natera, about their cell-free DNA (cfDNA) testing services.

From Natera 15 Apr 2022

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

Researchers investigated the potential of therapeutic drugs, remdesivir and dexamethasone, when used alone or in combination on neurological complications that arise in COVID-19 affected individuals.

14 Apr 2022

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism

A new study addresses the relationship between SARS-CoV-2 to the metabolism of one-carbon molecules in the host, suggesting new therapeutic pathways.

13 Apr 2022

Dietary influences on long COVID in children

A new study discusses possible mechanisms of long COVID in children and how they might relate to their dietary intake of important vitamins and elements.

13 Apr 2022

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

A new study has stated that the third booster dose of mRNA-based COVID-19 vaccines is 68% effective in preventing reinfection-related hospitalization among persons with a history of SARS-CoV-2.

13 Apr 2022

Private equity ownership of nursing homes triggers Capitol Hill questions — and a GAO probe

In his State of the Union address last month, President Joe Biden focused attention on how private equity ownership of nursing homes can affect residents' health.

13 Apr 2022

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

A recent scientific statement published in Circulation reviewed the current knowledge on COVID-19.

13 Apr 2022

Study explores myopericarditis incidence and COVID-19 vaccination

Researchers investigated the impact of COVID-19 vaccination on the incidence of myopericarditis.

13 Apr 2022

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Researchers examined the risk of breakthrough COVID-19 infections, hospitalizations, and mortality among COVID-19-vaccinated cancer patients.

13 Apr 2022

Comparing SARS-CoV-2 Delta and Omicron waves in Germany

In a recent study posted to the medRxiv* preprint server, researchers compared the outcomes and characteristics of hospitalized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients during the SARS-CoV-2 Delta and Omicron variants’ dominant periods in Germany.

12 Apr 2022

New analysis finds more cancer diagnosis through emergency routes in the UK

More cancers are being diagnosed through emergency routes in the UK than in comparable high-income countries, according to new analysis by the International Cancer Benchmarking Partnership (ICBP), which is hosted by Cancer Research UK.

12 Apr 2022

Thoracic aortic diameter serves as a biomarker for major cardiovascular events

The diameter of the thoracic aorta is a biomarker for heart attacks and other adverse cardiovascular events in women and men, according to a new study published in the journal Radiology.

12 Apr 2022

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

In a new study, researchers quantified the serological responses following the third dose of mRNA-based COVID-19 vaccines in patients with hematological malignancies.

12 Apr 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

A new study assessed the effectiveness of the BNT162b2 SARS-CoV-2 vaccine against Delta and Omicron variants in adolescents.

12 Apr 2022

UMass Amherst-based COVID-19 Forecast Hub generates accurate predictions of pandemic deaths

The University of Massachusetts Amherst-based U.S. COVID-19 Forecast Hub, a collaborative research consortium, has generated the most consistently accurate predictions of pandemic deaths at the state and national level, according to a paper published April 8 in the Proceedings of the National Academies of Sciences.

11 Apr 2022

New study reveals oral opaganib's potent in vitro activity against Omicron

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced study results in which opaganib (ABC294640), a leading oral drug candidate for hospitalized patients with moderate to severe COVID-19, was observed to have potent in vitro efficacy against the Omicron SARS-CoV-2 variant, while maintaining host cell viability.

11 Apr 2022

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

...

11 Apr 2022

Study finds higher risk of all-cause mortality among pediatric cancer patients in LMICs during the pandemic

During the first nine months of the COVID-19 pandemic, pediatric cancer patients from lower- and middle-income countries faced a higher risk of all-cause mortality than those in high-income countries, according to data presented at the AACR Annual Meeting 2022, held April 8-13.

11 Apr 2022

Tobacco use increased in smokers trying to quit during COVID-19, study finds

While smoking rates have declined dramatically in the United States, there are still 35 million smokers. There are few data about whether, and if so, how current cigarette smoking habits among those trying to quit are affected by the COVID-19 pandemic.

11 Apr 2022

Mortality News and Research

Insight into the future of genetic testing

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism

Dietary influences on long COVID in children

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

Private equity ownership of nursing homes triggers Capitol Hill questions — and a GAO probe

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

Study explores myopericarditis incidence and COVID-19 vaccination

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Comparing SARS-CoV-2 Delta and Omicron waves in Germany

New analysis finds more cancer diagnosis through emergency routes in the UK

Thoracic aortic diameter serves as a biomarker for major cardiovascular events

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

UMass Amherst-based COVID-19 Forecast Hub generates accurate predictions of pandemic deaths

New study reveals oral opaganib's potent in vitro activity against Omicron

COVID-19 increases risk of bleeding, DVT, and pulmonary embolism

Study finds higher risk of all-cause mortality among pediatric cancer patients in LMICs during the pandemic

Tobacco use increased in smokers trying to quit during COVID-19, study finds

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News